Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress – a brief review
Rajarshi Sil,
Abhay Sankar Chakraborti
Frontiers in Chemistry,
Год журнала:
2025,
Номер
13
Опубликована: Фев. 25, 2025
Oxidative
stress
is
considered
as
the
root-cause
of
different
pathological
conditions.
Transition
metals,
because
their
redox-active
states,
are
capable
free
radical
generation
contributing
oxidative
stress.
Hemoglobin
and
myoglobin
two
major
heme
proteins,
involved
in
oxygen
transport
storage,
respectively.
Heme
prosthetic
group
proteins
a
good
reservoir
iron,
most
abundant
transition
metal
human
body.
Although
iron
tightly
bound
pocket
these
it
liberated
under
specific
circumstances
yielding
ferrous
iron.
This
active
can
react
with
H2O2,
secondary
metabolite,
forming
hydroxyl
via
Fenton
reaction.
Hydroxyl
harmful
among
all
reactive
species.
It
causes
by
damaging
lipid
membranes,
nucleic
acids,
activating
inflammatory
pathways
altering
membrane
channels,
resulting
disease
In
this
review,
we
have
discussed
how
heme-irons
hemoglobin
promote
pathophysiological
conditions
including
metabolic
syndrome,
diabetes,
cardiovascular,
neurodegenerative
renal
diseases.
Understanding
association
to
may
be
important
for
knowing
complications
well
therapeutic
management
Язык: Английский
The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(8), С. 3707 - 3707
Опубликована: Апрель 14, 2025
The
AGE
(advanced
glycation
end-products)–RAGE
(receptor
for
AGE)
system
is
a
pro-inflammatory
pathway
that
contributes
to
the
pathogenesis
of
obesity
and
obesity-related
cardiovascular
disorders
(CVD).
Circulating
soluble
form
RAGE
(sRAGE)
has
been
suggested
as
potential
biomarker
CVD
related
obesity.
In
this
study,
we
aim
(1)
summarize
current
knowledge
about
role
in
onset
progression
CVD,
(2)
discuss
AGE–RAGE
promoting
linking
(3)
highlight
available
strategies
reducing
activation
associated
beneficial
effects.
Язык: Английский
Computational Biology in the Discovery of Biomarkers in the Diagnosis, Treatment and Management of Cardiovascular Diseases
Cardiology and Cardiovascular Medicine,
Год журнала:
2024,
Номер
8(5)
Опубликована: Янв. 1, 2024
Cardiovascular
diseases
are
the
leading
cause
of
mortality
worldwide,
with
a
disproportionately
high
burden
in
low-
and
middle-income
countries.
Biomarkers
play
crucial
role
early
detection,
diagnosis,
treatment
cardiovascular
by
providing
valuable
insights
into
normal
abnormal
conditions
heart
vascular
system.
The
biomarkers
derived
from
cells
tissues
can
be
identified
quantified
blood
other
body
fluids
tissues.
Changes
their
expression
level
under
pathological
condition
provide
clinical
information
on
underlying
pathophysiology
that
could
have
predictive,
diagnostic,
prognostic
value
disease
process,
therefore
incorporated
guidelines.
This
enhances
effectiveness
risk
stratification
therapeutic
decisions
personalized
medicine
improvement
patient
outcomes.
protein,
carbohydrate,
or
genome-based
may
also
lipids
nucleic
acids.
Computational
biology
has
emerged
as
powerful
discipline
biomarker
discovery,
leveraging
computational
techniques
to
identify
validate
biological
markers
for
prognosis,
drug
response
prediction.
convergence
advanced
technologies,
such
artificial
intelligence,
multi-omics
profiling,
liquid
biopsies,
imaging,
led
significant
shift
discovery
development
biomarkers,
enabling
integration
data
multiple
scales
more
comprehensive
understanding
complex
signaling
transcriptional
networks
pathogenesis.
In
this
article,
we
reviewed
integrated
genomics,
proteomics,
metabolomics,
together
machine
learning
predictive
modeling
diseases.
We
discussed
specific
including
epigenetic,
metabolic,
emerging
extracellular
vesicles,
miRNAs,
circular
RNAs,
Язык: Английский